In this study, IL-15 modified CD19 CAR T cells secreted IL15 following antigen stimulation, showed enhanced survival as a result of the transgenic cytokine, expanded better in vivo, and have better in vivo anti-tumor activity (45). Here, CD19 is linked to neoplasm.